Peter Hess was a reporter for Spectrum from 2019 to 2023, where he covered cannabinoids, autism prevalence, social hormones and other topics. Before joining Spectrum in 2019, he was associate science editor at Inverse, where he wrote and edited stories for a broad audience on a wide range of scientific topics, including drugs, evolution and environmental science. His work has also appeared in The Washington Post, New Scientist, Popular Science and Motherboard. Peter has an M.A. in science journalism from New York University’s Science, Health and Environmental Reporting Program. Find him on Twitter at @PeterNHess.
Peter Hess
Former news writer
Spectrum
From this contributor
Capturing autism’s sleep problems with devices nearable and wearable
Next-generation trackers could realize a long-standing research dream: conducting sleep studies in large numbers of autistic people.
Capturing autism’s sleep problems with devices nearable and wearable
By
Angie Voyles Askham, Peter Hess
6 June 2023 | 5 min read
Going on Trial: Epidiolex for autism; arbaclofen tests; pain monitoring
This month’s issue of Going on Trial takes a sneak peek at some early null results from a small trial of a cannabidiol-based drug for autism, among other recent drug developments.
Going on Trial: Epidiolex for autism; arbaclofen tests; pain monitoring
By
Peter Hess
30 May 2023 | 7 min read
Swings and misses with Jeremy Veenstra-VanderWeele
A careful clinician who prizes evidence, Jeremy Veenstra-VanderWeele is happy to embrace trial failures, as long as he learns from them.
Ruth Carper: Imaging the aging brain in autistic adults
Few studies have tracked how brain structure and function change across adulthood in people with autism. Carper and her colleagues are collecting data to fill this gap.
Ruth Carper: Imaging the aging brain in autistic adults
By
Peter Hess
19 May 2023 | 7 min read
Autism-related genes converge on microglia and dopamine in zebrafish
The findings add to the growing evidence that genes with disparate functions can play similar roles in brain development.
Autism-related genes converge on microglia and dopamine in zebrafish
By
Peter Hess
12 May 2023 | 4 min read
Explore more from The Transmitter
Commentary: Citation graphs may underestimate neuroscience’s influence on AI
An alternative, albeit less quantitative, way to trace this history is through the people who carried ideas between the fields.
Commentary: Citation graphs may underestimate neuroscience’s influence on AI
An alternative, albeit less quantitative, way to trace this history is through the people who carried ideas between the fields.
By
Anthony Zador
26 October 2026 | 5 min read
Commentary: The rising absolute number of neuro-inspired AI papers represents a substantial footprint
Many of the design choices present in the current generation of artificial-intelligence tools parallel purported properties of the brain.
Commentary: The rising absolute number of neuro-inspired AI papers represents a substantial footprint
Many of the design choices present in the current generation of artificial-intelligence tools parallel purported properties of the brain.
By
Kim Stachenfeld
26 October 2026 | 2 min read
Examining the bridge between neuroscience and AI
A citation analysis reveals that the connection between the two fields is real and gaining momentum. But it’s also narrow and tool-heavy; we need to find ways to widen it.
Examining the bridge between neuroscience and AI
A citation analysis reveals that the connection between the two fields is real and gaining momentum. But it’s also narrow and tool-heavy; we need to find ways to widen it.
By
Renato Duarte
26 October 2026 | 12 min read